Rheumacare capsules recall
FDA recall D-0332-2026 · initiated Dec 22, 2025
HANDELNINE GLOBAL LLC recalled Rheumacare capsules in Dec 2025 — an FDA Class I recall (D-0332-2026) because CGMP Deviations: product found to contain lead.
Most serious — a reasonable probability that use will cause serious harm or death.
Why it was recalled
CGMP Deviations: product found to contain lead.
The manufacturing process itself
The FDA found the process itself out of compliance, usually before any defective product was identified.
This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.
Is your product affected? Check the lot number
A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.
Quantity recalled: 4 bottles /30 capsules each
Details
- Product
- Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India UPC 8 904218 700313
- Recalling company
- HANDELNINE GLOBAL LLC
- Classification
- Class I
- Status
- Ongoing
- Type
- Voluntary: Firm initiated
- Distribution
- Product was distributed to one customer in NY.
- Initiated
- Dec 22, 2025
- FDA report date
- Feb 11, 2026
Frequently asked
- Was Rheumacare capsules recalled?
- HANDELNINE GLOBAL LLC recalled Rheumacare capsules in Dec 2025 — an FDA Class I recall (D-0332-2026) because CGMP Deviations: product found to contain lead. Most serious — a reasonable probability that use will cause serious harm or death.
- Why was Rheumacare capsules recalled?
- Per the FDA enforcement record, the reason for recall D-0332-2026 was: CGMP Deviations: product found to contain lead.
- Is a recalled Rheumacare capsules dangerous to take?
- An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. Most serious — a reasonable probability that use will cause serious harm or death. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
- Which lots of Rheumacare capsules are affected?
- Distributed: Product was distributed to one customer in NY.. The recall covers these lots — Lot: CAM040, Exp. 06/30/2029 Lot: CAL079-N, Exp. 09/30/2028. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0332-2026.